A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study
Jens Lundgren(Centre of Excellence for Health, Immunity and Infections)
Cited by 129
Related Papers
Machine learning can identify newly diagnosed patients with CLL at high risk of infection
|Nature Communications|2020|125
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
|The Journal of Infectious Diseases|2023|77